“Besides the success with FENO-ARONIA and FENO-CHAGA™, we also achieved a possible raw-material partnership, which could put us in a very strong position on one key raw material. We were also graced with the support of our Board member, Dr. Diane Clayton, who supported us in many customer meetings and liaised with many scientists that were presenting at various seminars at the show, building our scientific network. This was a good week for Eevia Health,” states Stein Ulve, Eevia’s Chief Executive Officer.

Eevia Health experienced a highly favorable reception at the Vitafoods 2025 tradeshow in Barcelona this week. The event resulted in new orders from both existing and new clients, along with promising new prospects. Eevia unveiled an innovative health ingredient, FENO-ARONIA™ 50 Organic, which garnered significant interest and secured two initial orders. Furthermore, Eevia forged a Global Supply agreement for FENO-CHAGA™ Organic through a collaboration with a new associate.

Vitafoods, a premier gathering for the nutraceutical sector, drew over 21,500 professionals from more than 160 nations to Barcelona this year. Renowned for its emphasis on high-quality offerings, it serves as a crucial hub within the industry.

At the tradeshow, Eevia introduced FENO-ARONIA™ 50 Organic, a distinctive, high-potency, excipient-free health ingredient boasting an unparalleled concentration of bioactive polyphenols. This product, derived from organically cultivated Aronia in Finland, is manufactured by Eevia using organic green chemistry principles. It generated substantial interest and led to two immediate orders, marking the quickest progression from launch to sales in the Company’s history.

Additionally, Eevia finalized a long-term agreement concerning FENO-CHAGA™ Organic with a new strategic collaborator.

Our team in pictured from left to right are: Erik, Diane, Anna-Maija, and Stein.